Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 4 2Phase 1/2 1

Status

Withdrawn 1Terminated 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 104Carcinoma, Hepatocellular 103Stomach Neoplasms 62Pancreatic Neoplasms 46Liver Neoplasms 38Colonic Neoplasms 37Esophageal Neoplasms 28Rectal Neoplasms 22Neoplasms 13Neoplasm Metastasis 13Gastrointestinal Neoplasms 12Barrett Esophagus 11Recurrence 10Gastrointestinal Stromal Tumors 10Breast Neoplasms 10Bile Duct Neoplasms 10Pain, Postoperative 9Lung Neoplasms 8Cholangiocarcinoma 8Head and Neck Neoplasms 7Malnutrition 6Hepatitis B 6Carcinoma, Non-Small-Cell Lung 6Biliary Tract Neoplasms 6Agnosia 6Adenocarcinoma 6Prostatic Neoplasms 5Postoperative Complications 5Peptic Ulcer 5Pain 5

Interventions

Pancrelipase 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Exocrine Pancreatic Insufficiency × Gastrointestinal × Clear all
NCT03859869 2023-06-05

A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)

AbbVie

Phase 4 Terminated
1 enrolled 6 charts
Gastrointestinal

Exocrine Pancreatic Insufficiency, Pancreatic Neoplasms

NCT04315311 2021-11-08

Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic Cancer

AbbVie

Phase 4 Withdrawn
Gastrointestinal

Exocrine Pancreatic Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡